Literature DB >> 9452423

Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta.

P Domanski1, O W Nadeau, L C Platanias, E Fish, M Kellum, P Pitha, O R Colamonici.   

Abstract

The signaling specificity for cytokines that have common receptor subunits is achieved by the presence of additional cytokine-specific receptor components. In the type I interferon (IFN) family, all 14 subtypes of IFNalpha, IFNbeta, and IFNomega bind to the same alpha and betaL subunits of the type I IFN-R, yet differences in signaling and biological effects exist among them. Our data demonstrate that IFNalpha2 and IFNbeta utilize different regions of the betaL subunit for signaling. Thus, in contrast to other cytokine systems, signal diversity in the type I IFN system can be accomplished within the same receptor complex by utilizing different regions of the same receptor subunits.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452423     DOI: 10.1074/jbc.273.6.3144

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.

Authors:  R Deonarain; A Alcamí; M Alexiou; M J Dallman; D R Gewert; A C Porter
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.

Authors:  M Enomoto; A Tamori; N Kawada; H Jomura; S Nishiguchi; T Saibara; S Onishi; S Mochida; K Fujiwara
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

3.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

4.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.

Authors:  Sabine R Quadt-Akabayov; Jordan H Chill; Rina Levy; Naama Kessler; Jacob Anglister
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

6.  The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection.

Authors:  Kristina Abel; Michelle J Alegria-Hartman; Kristina Rothaeusler; Marta Marthas; Christopher J Miller
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.

Authors:  Diego A Jaitin; Laila C Roisman; Eva Jaks; Martynas Gavutis; Jacob Piehler; Jose Van der Heyden; Gilles Uze; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines.

Authors:  Christine Rogez; Marc Martin; Nathalie Dereuddre-Bosquet; Jacques Martal; Dominique Dormont; Pascal Clayette
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  STAT-phosphorylation-independent induction of interferon regulatory factor-9 by interferon-beta.

Authors:  M R Sandhya Rani; Ed Croze; Tao Wei; Jennifer Shrock; Anupama Josyula; Dhananjaya V Kalvakolanu; Richard M Ransohoff
Journal:  J Interferon Cytokine Res       Date:  2010-03       Impact factor: 2.607

10.  Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs.

Authors:  Ko Sato; Hideki Yamamoto; Toshiki Nomura; Ikumi Matsumoto; Tomomitsu Miyasaka; Tong Zong; Emi Kanno; Kazuko Uno; Keiko Ishii; Kazuyoshi Kawakami
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.